WASHINGTON, D.C. - U.S. Sen. Sherrod Brown (D-OH) is demanding answers from the CEO of Mylan, the maker of the EpiPen Auto-Injector, following a massive price hike. As of May 2016, Mylan had increased the price of this life-saving device by over 480 percent - from $103.50 for a set of two in 2009 to $608.61 today - while Mylan's own CEO's compensation grew 670 percent.
"Parents of children with severe allergies live in fear each day that their children will have an allergic reaction. They shouldn't also have to worry about whether they can afford the life-saving device that can protect their sons and daughters," said Brown. "This price gouging hurts families who already struggle to get by - all while Mylan's CEO collects an outrageous salary. The company owes the American people more than just an explanation - we need to see action to bring down the cost of this drug so it is accessible to those who need it."
To read the full article, click the link below.Sherrod Brown demands answers on EpiPen price hike »